- Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Characterization of the evolutionary and virological aspects of mutations in the receptor binding motif of the SARS-CoV-2 spike protein2023 | First Faculty of Medicine
- SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers2022 | First Faculty of Medicine
- Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test2021 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease2023 | Second Faculty of Medicine
- Blokátory renin-angiotenzinového systému a COVID-192021 | First Faculty of Medicine
- Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics2023 | First Faculty of Medicine
- Thus spoke peptides: SARS-CoV-2 spike gene evolved in humans and then shortly in rats while the rest of its genome in horseshoe bats and then in treeshrews2022 | Faculty of Science
- Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant2023 | First Faculty of Medicine
- Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic2022 | First Faculty of Medicine
- Active site-based analysis of structural proteins for drug targets in different human Coronaviruses2022 | Faculty of Science
- From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic-Associated Pernio2021 | Second Faculty of Medicine
- Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights2020 | First Faculty of Medicine
- Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant2023 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Relationship between Acute-Phase Symptoms and Immunoglobulin G Seropositivity up to Eight Months after COVID-192022 | First Faculty of Medicine
- Exposing and exploiting host–parasite arms race clues in SARS-CoV-2: a principally new method for improved T cell immunogenicity prediction2023 | First Faculty of Medicine, Faculty of Science
- Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions2021 | Faculty of Medicine in Hradec Králové
- Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic2022 | Faculty of Medicine in Pilsen
- Declining neutralizing antibody levels after SARS-CoV-2 mRNA vaccination: observational data from community point-of-care testing service in Brno, Czechia2022 | First Faculty of Medicine
- The kinetics and predictors of anti-SARS-CoV-2 antibodies up to 8 months after symptomatic COVID-19: A Czech cross-sectional study2022 | First Faculty of Medicine
- Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- From SARS-CoV-2 to analgesia: harnessing the VEGF-A/NRP-1 axis for pain therapy2023 | Third Faculty of Medicine
- Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients - A Czech Multicenter Experience2022 | Third Faculty of Medicine